EUVIMEDEUVIMED entdecken
Crossref

Prediction of Clinically Significant Prostate Cancer Using Multiparametric MRI, Biparametric MRI, and Clinical Parameters

Maximilian Oberneder, Thomas Henzler, Martin Kriegmair, Tibor Vag, Matthias Roethke, Sabine Siegert, Roland Lang, Julia Lenk, Joshua Gawlitza

Urologia Internationalis · 2024

DOI: 10.1159/000541152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Urologia Internationalis, 2024. Verfasst von Maximilian Oberneder und 8 weiteren Autor:innen. Beteiligte Einrichtung: Urologische Klinik München-Planegg, Planegg, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging, Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Multiparametric MRI (mpMRI) is gold standard for the primary diagnostic work-up of clinically significant prostate cancer (csPCa). The aim of this study was to assess the benefit of the perfusion sequence and the non-inferiority of an MRI without contrast administration (bpMRI) compared to mpMRI while taking clinical parameters into account.

Methods

In this retrospective, non-interventional study we examined MRI data from 355 biopsy-naïve patients, performed on a 3T MRI system, evaluated by a board-certified radiologist with over 10 years of experience with subsequent mpMRI-TRUS fusion biopsy.

Discussion

Only 16/355 (4.5%) patients benefited from dynamic contrast enhanced. In only 3/355 (0.8%) patients, csPCa would have been missed in bpMRI. BpMRI provided sensitivity and specificity (81.4%; 79.4%) comparable to mpMRI (75.2%; 81.8%). Additionally, bpMRI and mpMRI were independent predictors for the presence of csPCa, individually (OR: 15.36; p < 0.001 vs. 12.15; p = 0.006) and after accounting for established influencing factors (OR: 12.81; p < 0.001 vs. 6.50; p = 0.012). When clinical parameters were considered, a more balanced diagnostic performance between sensitivity and specificity was found for mpMRI and bpMRI. Overall, PSA density showed the highest diagnostic performance (area under the curve = 0.81) for the detection of csPCa.

Conclusion

The premise of the study was confirmed. Therefore, bpMRI should be adopted as soon as existing limitations have been lifted by prospective multi-reader studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMultiparametric Magnetic Resonance ImagingMagnetic Resonance ImagingHumansMaleRetrospective StudiesMiddle AgedAgedPredictive Value of TestsContrast Media

Stichwörter der Autor:innen

Biparametric MRIDynamic contrast enhanced MRIMultiparametric MRIProstate cancerProstate-specific antigen density

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Urologische Klinik München-Planegg, Planegg, Germany.
  • RH Diagnostik und Therapie GmbH, Munich, Germany.
  • Conradia Radiologie, Munich, Germany.
  • Ihre-Radiologen.de MVZ GmbH, Berlin, Germany.
  • Pathologie München-Nord, Munich, Germany.
  • Radiology Department, Klinikum rechts der Isar der TUM, Munich, Germany.

Zitieren

APA

Oberneder, M., Henzler, T., Kriegmair, M., Vag, T., Roethke, M., Siegert, S., Lang, R., Lenk, J., & Gawlitza, J. (2024). Prediction of Clinically Significant Prostate Cancer Using Multiparametric MRI, Biparametric MRI, and Clinical Parameters. Urologia Internationalis. https://doi.org/10.1159/000541152

Vancouver

Oberneder M, Henzler T, Kriegmair M, Vag T, Roethke M, Siegert S, et al. Prediction of Clinically Significant Prostate Cancer Using Multiparametric MRI, Biparametric MRI, and Clinical Parameters. Urologia Internationalis. 2024. doi:10.1159/000541152

BibTeX
@article{Oberneder2024,
  author = {Oberneder, Maximilian and Henzler, Thomas and Kriegmair, Martin and Vag, Tibor and Roethke, Matthias and Siegert, Sabine and Lang, Roland and Lenk, Julia and Gawlitza, Joshua},
  title = {Prediction of Clinically Significant Prostate Cancer Using Multiparametric MRI, Biparametric MRI, and Clinical Parameters},
  journal = {Urologia Internationalis},
  year = {2024},
  doi = {10.1159/000541152}
}
Kostenlos starten →